A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

Radiotherapy and Oncology

Volumn 44, Issue 2, 1997, Pages 123-136

  Dische, Stanley ^a   Saunders, Michele ^a   Barrett, Ann ^b   Harvey, Angela ^c   Gibson, Della ^c   Parmar, Mahesh ^c  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Accelerated radiotherapy; CHART; Controlled trial; Head and neck

Indexed keywords

ADULT; AGED; ARTICLE; BONE NECROSIS; CANCER CONTROL; CANCER SURVIVAL; CHONDRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY;

EID: 0030739859     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)00094-7     Document Type: Article

References (21)

1. Aird, E.G.A., Williams, C., Mott, G.T.M., Dische, S. and Saunders, M.I. Quality assurance in the CHART clinical trial. Radiother. Oncol. 36: 235-245, 1995.
2. Coyle, D. and Drummond, M. (on behalf of the CHART Steering Committee). Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer and carcinoma of the bronchus. Clin. Oncol., 1997, in press.
3. Dische, S. Regaud Lecture, Malmö, 1992. The clinical science of radiation oncology, Radiother. Oncol, 28: 93-107, 1993.
4. Dische, S., Warburton, M.F., Jones, D. and Lartigau, E. The recording of morbidity related to radiotherapy. Radiother. Oncol. 16: 103-108, 1989.
5. Fowler, J.F. Fractionated radiation therapy after Standqvist. Acta Radiol. Oncol. 23: 209-216, 1984.
6. Hansen, O., Overgaard, J., Hansen, H.S., Overgaard, M., Høyer, M., Jørgensen, K.E. et al. Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation. Radiother. Oncol. 43: 47-51, 1997.
7. Horiot, J.C., Bontemps, P., van den Bogaert, W., Le Fur, R., van den Weijngaert, D., Bolla, M. et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 Randomized Trial. Radiother. Oncol., 1997, in press.
8. International Commission on Radiation Units and Measurements, Report 29. Dose specification for reporting external beam therapy with photons and electrons, 1978.
9. Leslie, M.D. and Dische, S. Parotid gland function following accelerated and conventionally fractionated radiotherapy. Radiother. Oncol. 22: 133-139, 1991.
10. Million, R.R. The larynx...so to speak: everything I wanted to know about laryngeal cancer I learned in the last 32 years. Int. J. Radiat. Oncol. Biol. Phys. 23: 691-704, 1992.
11. Overgaard, J., Hansen, H.S., Jørgensen, K. and Hansen, M.H. Primary radiotherapy of larynx and pharynx carcinoma - an analysis of some factors influencing local control and survival. Int. J. Radiat. Oncol. Biol. Phys. 12: 515-521, 1986.
12. Overgaard, J., Hansen, H.S., Sapru, W., Overgaard, M., Grau, C., Jørgensen, K. et al. Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week -preliminary report from the DAHANCA 6 and 7 trial. Radiother. Oncol 40 (Suppl. 1): S31, 1996.
13. Parmar, M.K.B., Spiegelhalter, D.J., Freedman, L.S. and the CHART Steering Committee. The CHART trials: Bayesian design and monitoring in practice. Stat. Med. 13: 1297-1312, 1994.
14. Saunders, M.I. Accelerated hyperfractionation in non small cell lung cancer. In: Lung Cancer - Principles and Practice, pp. 721-727. Editors: H. Pass, J. Mitchell, D. Johnson and A. Turrisi. J.B. Lippincott, Philadelphia, PA, 1996.
15. Saunders, M.I. and Dische, S. Radiotherapy employing three fractions in each day over a continuous period of 12 days. Br. J. Radiol. 59: 523-525, 1986.
16. Saunders, M.I., Dische, S., Barrett, A., Parmar, M.K.B., Harvey, A. and Gibson, D. (on behalf of the CHART Steering Committee). Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small cell lung cancer: an interim report. Br. J. Cancer 73: 1455-1462, 1996.
17. Saunders, M.I., Dische, S., Grosch, E.J., Fermont, D.C., Ashford, R.F.U., Maher, E.J. and Makepeace, A.R. Experience with CHART. Int. J. Radiat. Oncol. Biol. Phys. 21: 871-878, 1991.
18. Saunders, M.I., Dische, S., Hong, A., Grosch, E.J., Fermont, D.C., Ashford, R.F.U. et al. Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck region. Int. J. Radiat. Oncol. Biol. Phys. 17: 1287-1293, 1989.
19. Trott, K.R. and Kummermehr, J. What is known about tumour proliferation rates to choose between accelerated fractionation or hyper-fractionation. Radiother. Oncol. 3: 1-9, 1985.
20. Wilson, G.D., Dische, S. and Saunders, M.I. Studies in bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother. Oncol. 36: 189-197, 1995.
21. Wilson, G.D., McNally, N.J., Dische, S. and Bennett, M.H. Cell proliferation in human tumours measured by in vivo labelling with bromodeoxyuridine. Br. J. Radiol. 61: 419-422, 1988.